Through in silico analysis, we identified 22 candidate genes that contained both ARE and ERE within the promoter region and confirmed that interleukin-8 (IL-8) had both functional ARE and ERE activity (Figure S1), suggesting that IL-8 could be regulated by both AR and ER in ER+ve breast cancer. This evidence concerns the gene CXCL8 and breast carcinoma.